bosentan anhydrous has been researched along with MODS in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guc, O; Iskit, AB | 1 |
| Mitaka, C | 1 |
| Bäcker, A; Bader, M; Dvorák, P; Ganten, D; Janda, J; Kopkan, L; Kramer, HJ; Malý, J; Opocenský, M; Tesar, V; Vanecková, I; Vernerová, Z; Zima, T | 1 |
2 review(s) available for bosentan anhydrous and MODS
| Article | Year |
|---|---|
Effects of endothelin and nitric oxide on organ injury, mesenteric ischemia, and survival in experimental models of septic shock.
Topics: Animals; Bacterial Translocation; Bosentan; Endothelin Receptor Antagonists; Endothelins; Guanidines; Humans; Multiple Organ Failure; Nitric Oxide; Nitric Oxide Synthase; Shock, Septic; Splanchnic Circulation; Sulfonamides | 2003 |
[Septic shock and endothelin].
Topics: Animals; Bosentan; Bronchoconstriction; Capillary Permeability; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Humans; Multiple Organ Failure; Peptides, Cyclic; Receptor, Endothelin A; Receptor, Endothelin B; Shock, Septic; Sulfonamides; Vasoconstriction | 2004 |
1 other study(ies) available for bosentan anhydrous and MODS
| Article | Year |
|---|---|
Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats.
Topics: Administration, Oral; Animals; Animals, Genetically Modified; Blood Pressure; Bosentan; Endothelin Receptor Antagonists; Female; Hypertension; Male; Multiple Organ Failure; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Renin; Renin-Angiotensin System; Severity of Illness Index; Sodium Chloride; Sulfonamides; Survival Rate | 2004 |